Displaying 1 drug
Upadacitinib
Upadacitinib is an oral Janus kinase (JAK)1-selective inhibitor and a disease-modifying antirheumatic drug (DMARD) used in the treatment of rheumatoid arthritis to slow down disease progression. Rheumatoid arthritis is a chronic autoimmune inflammatory disease affecting the peripheral joints. It is characterized by synovial inflammation and hyperplasia, autoantibody production, cartilage damage...
Approved
Investigational
Matched Synonyms: … Upadacitinib …
Matched Name: … Upadacitinib …
Matched Description: … Upadacitinib is an oral Janus kinase (JAK)1-selective inhibitor and a disease-modifying antirheumatic ... [A189165] The FDA approved upadacitinib in August 2019 and it is used for the treatment of active ... and [filgotinib], were developed. …
Matched Salts name: … Upadacitinib tartrate ... Upadacitinib hemihydrate …
Matched Categories: … upadacitinib ... Antineoplastic and Immunomodulating Agents …
Matched Name: … Upadacitinib …
Matched Description: … Upadacitinib is an oral Janus kinase (JAK)1-selective inhibitor and a disease-modifying antirheumatic ... [A189165] The FDA approved upadacitinib in August 2019 and it is used for the treatment of active ... and [filgotinib], were developed. …
Matched Salts name: … Upadacitinib tartrate ... Upadacitinib hemihydrate …
Matched Categories: … upadacitinib ... Antineoplastic and Immunomodulating Agents …
Displaying 1 drug